Palmitoyl-L-carnitine chloride
SIGMA/P1645 - ≥98% (TLC), powder
Synonym: O-Palmitoyl-L-carnitine chloride
CAS Number: 18877-64-0
Empirical Formula (Hill Notation): C23H46ClNO4
Molecular Weight: 436.07
EC Number: 242-642-6
MDL Number: MFCD00070346
Linear Formula: C23H46NO4 · Cl
Product Type: Chemical
| assay | ≥98% (TLC) |
| color | white |
| form | powder |
| InChI | 1S/C23H45NO4.ClH/c1-5-6-7 |
| InChI key | GAMKNLFIHBMGQT-ZMBIFBSDSA |
| lipid type | saturated FAs |
| Quality Level | 200 ![]() |
| SMILES string | [Cl-].CCCCCCCCCCCCCCCC(=O |
| solubility | H2O: 25 mg/mL (with heat or sonication) |
| storage temp. | −20°C |
| Application: | Palmitoyl- |
| Biochem/physiol Actions: | Long-chain acylcarnitine and well-known intermediate in mitochondrial fatty acid oxidation. Modifies myocardial levels of high-energy phosphates and free fatty acids in the heart. Increases erythroid colony formation in culture. Reduces surface negative charge of erythrocytes and myocytes. Reported to affect currents and inhibit endothelium-dependent relaxation induced by acetylcholine and substance P in a dose-dependent manner by suppressing the intracellular calcium signal transduction in endothelial cells. Inhibits the Na/K pump current but has no effect on the intracellular calcium current in guinea pig ventricular cells. However, like oubain, it reversibly depolarizes the resting membrane, decreases action potential duration, and increases the amplitude of myocyte contractions. |
| Packaging: | 10, 25 mg in poly bottle |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352211 |


